New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
World experts set agenda to improve care of acute kidney injury in kids

World experts set agenda to improve care of acute kidney injury in kids

by Ann & Robert H. Lurie Children's Hospital of ChicagoCredit: Pixabay/CC0 Public DomainAcute kidney injury occurs (AKI) in one out of four babies, children and young adults during an int
Pediatrics June 17,2024
World experts set agenda to improve care of acute kidney injury in kids

World experts set agenda to improve care of acute kidney injury in kids

by Ann & Robert H. Lurie Children's Hospital of ChicagoCredit: Pixabay/CC0 Public DomainAcute kidney injury occurs (AKI) in one out of four babies, children and young adults during an int
Pediatrics June 17,2024
What causes SIDS? Study suggests genetics may be at play in sudden infant death syndrome

What causes SIDS? Study suggests genetics may be at play in sudden infant death syndrome

by Adrianna RodriguezCredit: Pixabay/CC0 Public DomainThe cause of sudden infant death syndrome, or SIDS, continues to be a medical mystery but a new study suggests genetics may play a role.Over the c
Pediatrics June 17,2024
What causes SIDS? Study suggests genetics may be at play in sudden infant death syndrome

What causes SIDS? Study suggests genetics may be at play in sudden infant death syndrome

by Adrianna RodriguezCredit: Pixabay/CC0 Public DomainThe cause of sudden infant death syndrome, or SIDS, continues to be a medical mystery but a new study suggests genetics may play a role.Over the c
Pediatrics June 17,2024
World's first studies with bedside portable MRI in pediatric ECMO patients

World's first studies with bedside portable MRI in pediatric ECMO patients

by Petra Sandow,University of BonnRepresenting T1 and T2-weighted images from the four patients receiving pMRI during ECLS treatment. In Patient 3 pMRI showed right hemispheric intracerebral hem
Emergency Medicine & Critical Care June 17,2024
World's first studies with bedside portable MRI in pediatric ECMO patients

World's first studies with bedside portable MRI in pediatric ECMO patients

by Petra Sandow,University of BonnRepresenting T1 and T2-weighted images from the four patients receiving pMRI during ECLS treatment. In Patient 3 pMRI showed right hemispheric intracerebral hem
Emergency Medicine & Critical Care June 17,2024
Are too many young children drinking specialized formula?

Are too many young children drinking specialized formula?

by WileyCredit: Unsplash/CC0 Public DomainNew research published inClinical and Experimental Allergyreveals that prescriptions of specialized infant formula have increased in recent y
Pediatrics June 17,2024
Are too many young children drinking specialized formula?

Are too many young children drinking specialized formula?

by WileyCredit: Unsplash/CC0 Public DomainNew research published inClinical and Experimental Allergyreveals that prescriptions of specialized infant formula have increased in recent y
Pediatrics June 17,2024
Skin-to-skin contact key for premature baby survival, WHO says in shift

Skin-to-skin contact key for premature baby survival, WHO says in shift

Credit: CC0 Public DomainSkin-to-skin contact is key to improving survival of premature and small babies, the WHO said on Tuesday in a major overhaul of policy that previously called for the use of in
Pediatrics June 17,2024
Skin-to-skin contact key for premature baby survival, WHO says in shift

Skin-to-skin contact key for premature baby survival, WHO says in shift

Credit: CC0 Public DomainSkin-to-skin contact is key to improving survival of premature and small babies, the WHO said on Tuesday in a major overhaul of policy that previously called for the use of in
Pediatrics June 17,2024
Genetic mechanisms may reveal retinal vascular disease therapeutic targets

Genetic mechanisms may reveal retinal vascular disease therapeutic targets

by Melissa Rohman,Northwestern UniversityEarly postnatal endothelial-specific deletion of Foxc1 impairs the blood-retinal barrier. Credit: Tsutomu Kume, Ph.D.Investigators led by Tsutomu Kume, P
Ophthalmology June 15,2024
Genetic mechanisms may reveal retinal vascular disease therapeutic targets

Genetic mechanisms may reveal retinal vascular disease therapeutic targets

by Melissa Rohman,Northwestern UniversityEarly postnatal endothelial-specific deletion of Foxc1 impairs the blood-retinal barrier. Credit: Tsutomu Kume, Ph.D.Investigators led by Tsutomu Kume, P
Ophthalmology June 15,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com